Podcast charts
Published by National Ataxia Foundation
NAF This Week brings you the latest news, updates, stories, and opportunities from the National Ataxia Foundation. NAF is a nonprofit organization dedicated to accelerating the development of treatments and improving the lives of people affected by Ataxia. Each episode helps you stay connected to what’s happening across the Ataxia community, from research and advocacy to programs, events, and ways to get involved. Learn more at www.ataxia.org.
On the charts
Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.
From the feed
The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.
Welcome to Episode #7 of NAF This Week! Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community — from research and advocacy to programs, events, and more. In this episode: This week, Andrew discusses the latest developments in Biohaven's resubmitted FDA application for troriluzole, an investigational treatment for Spinocerebellar Ataxia (SCA). He looks back at the drug's regulatory journey, explains the steps that have led to this point, and shares what may come next for the Ataxia community. Links & Resources Mentioned: 🔗 Biohaven SEC Filing: https://www.sec.gov/Archives/edgar/data/1935979/000193597926000083/bhvn-20261022.htm 🔗 What is an Investigational New Drug (IND) application?: https://www.ataxia.org/what-is-an-investigational-new-drug-ind-application/ 🔗 All About PDUFA Dates: https://www.ataxia.org/all-about-pdufa-dates/ Stay Connected with NAF: Visit www.ataxia.org to learn more about Ataxia, find resources and support, get involved, and follow the latest progress in Ataxia research.
Welcome to Episode #6 of NAF This Week! Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community — from research and advocacy to programs, events, and more. In this episode: This week, Andrew discusses recent FDA developments and what a new rare disease framework could mean for the Ataxia community. He highlights the importance of patient engagement, outside expertise, and a more predictable drug development process, along with opportunities for the community to learn more and get involved. Links & Resources Mentioned: 🔗 Rare Disease Framework Public Meeting – October 28: www.reaganudall.org/news-and-events/events/rare-disease-framework-public-meeting 🔗 FDA White Paper – A New Framework for Rare Disease Review: www.fda.gov/media/195694/download?attachment 🔗 Information about SARA Scores: www.ataxia.org/scasourceposts/snapshot-what-is-the-f-sara Stay Connected with NAF: Visit www.ataxia.org to learn more about Ataxia, find resources and support, get involved, and follow the latest progress in Ataxia research.
Welcome to Episode #5 of NAF This Week! Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community — from research and advocacy to programs, events, and more. In this episode: This week, Andrew shares his excitement about the recent Extreme Hike, which has raised more than $250K so far, and admits to having a little FOMO! He also highlights NAF's partnerships with FARA and Ataxia UK for the upcoming International Ataxia Research Conference (ICAR) and discusses NAF's continued growth and what it means for the organization's future and the Ataxia community. Links & Resources Mentioned: 🔗 Extreme Hike: https://www.ataxia.org/hike 🔗 ICAR: https://ataxiacongress.org 🔗 FARA: https://www.curefa.org/ 🔗 Ataxia UK: https://www.curefa.org/ 🔗 Advocacy: https://www.ataxia.org/advocacy Stay Connected with NAF: Visit www.ataxia.org to learn more about Ataxia, find resources and support, get involved, and follow the latest progress in Ataxia research.
Welcome to Episode 4 of NAF This Week! Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community — from research and advocacy to programs, events, and more. In this episode: In episode 4 of NAF This Week, Andrew reflects on the loss of Dr. Susan Perlman, a beloved leader and pioneer in the Ataxia field whose contributions have made a lasting impact on our community. He also shares highlights from his recent travels to Washington, D.C., and Boston, where he is participating in conferences focused on rare disease research, collaboration, and efforts to advance treatments. Links & Resources Mentioned: 🔗 Ask the Expert with Dr. Sue Perlman: www.ataxia.org/asktheexpert 🔗 Milken Institute FasterCures: https://milkeninstitute.org/health/fastercures 🔗 Act for ALS: https://milkeninstitute.org/health/fastercures 🔗 Synapticure: https://www.synapticure.com/with/ataxia 🔗 N-Lorem Foundation: https://www.nlorem.org/ Stay Connected with NAF: Visit www.ataxia.org to learn more about Ataxia, find resources and support, get involved, and follow the latest progress in Ataxia research.
Welcome to Episode 3 of NAF This Week! Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community - from research and advocacy to programs, events, and more. In this episode: This week on NAF This Week, Andrew shares a behind-the-scenes look at the CRC-SCA face-to-face meeting, where principal investigators and coordinators from research study sites come together to discuss the ongoing natural history study of Ataxia. Learn how this collaboration helps researchers better understand Ataxia and supports progress toward future treatments. Links & Resources Mentioned: 🔗 CRC-SCA: www.ataxia.org/crc-sca/ 🔗 NAF Drug Development Collaborative: www.ataxia.org/crc-sca/interested-industries/ Stay Connected with NAF: Visit www.ataxia.org to learn more about Ataxia, find resources and support, get involved, and follow the latest progress in Ataxia research. Subscribe to our channel and join us each week for NAF This Week: nafbx.podbean.com/
Welcome to Episode 2 of NAF This Week! Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community — from research and advocacy to programs, events, and more. In this episode: Andrew shares a firsthand recap of the 8th Annual United Against Ataxia Hill Day after a full day of meetings with members of Congress. He also breaks down the key asks NAF and FARA advocates brought to Capitol Hill on behalf of the Ataxia community and why they matter. Links & Resources Mentioned: 🔗 Ataxia Advocacy: www.ataxia.org/advocacy/ 🔗 United Against Ataxia Hill Day: www.ataxia.org/advocacy/hillday/ Stay Connected with NAF: Visit www.ataxia.org to learn more about Ataxia, find resources and support, get involved, and follow the latest progress in Ataxia research. Subscribe to our channel and join us each week for NAF This Week: nafbx.podbean.com/
Welcome to Episode 1 of NAF This Week! Join National Ataxia Foundation CEO Andrew Rosen for a quick look at what’s happening across NAF and the Ataxia community – from research and advocacy to programs, events, and more. In this episode: Andrew introduces NAF This Week and shares what you can expect from the new podcast. He also highlights Walk N’ Roll events happening across the country and encourages the community to get involved. Plus, with Hill Day coming up next week, Andrew shares what advocates will be doing to raise awareness and speak up for the Ataxia community. Links & Resources Mentioned: 🔗Walk N’ Roll to Cure Ataxia: www.ataxia.org/walk-n-roll/ 🔗United Against Ataxia Hill Day: www.ataxia.org/advocacy/hillday/ Stay Connected with NAF: Visit www.ataxia.org to learn more about Ataxia, find resources and support, get involved, and follow the latest progress in Ataxia research. Subscribe to our channel and join us each week!
Ranking source
Apple Podcasts rankings via the Mato Topic Intelligence Platform.
Observed November 4, 2026.
Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.
Pairs with
Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.